Evidence map›Paper›PMID 26316303›Full record

ArticleJournal of molecular and cellular cardiology2015

Cardiomyocytes induce macrophage receptor shedding to suppress phagocytosis.

Shuang Zhang, Xin-Yi Yeap, Lubov Grigoryeva, Shirley Dehn, Matthew DeBerge, Michael Tye, Emily Rostlund, Dorien Schrijvers, Zheng Jenny Zhang, Ronen Sumagin and 5 more

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Macrophage Efferocytosis in Heart.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  3. Article
  4. More Than a Cleanup Crew: The Expanding Biology of Efferocytosis.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  5. Review
  6. Review
  7. Efferocytosis: The Silent Guardian of Tissue Homeostasis and Cardiovascular Health.Journal of cardiovascular development and disease · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Immunometabolism at the Heart of Cardiovascular Disease.JACC. Basic to translational science · 2023
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Shuang ZhangFeinberg Cardiovascular Research Institute, Northwestern University, Chicago, IL, USA; Surgery-Organ Transplantation, Northwestern University, Chicago, IL, USA.
Xin-Yi YeapFeinberg Cardiovascular Research Institute, Northwestern University, Chicago, IL, USA; Surgery-Organ Transplantation, Northwestern University, Chicago, IL, USA.
Lubov GrigoryevaFeinberg Cardiovascular Research Institute, Northwestern University, Chicago, IL, USA; Surgery-Organ Transplantation, Northwestern University, Chicago, IL, USA.
Shirley DehnFeinberg Cardiovascular Research Institute, Northwestern University, Chicago, IL, USA; Surgery-Organ Transplantation, Northwestern University, Chicago, IL, USA.
Matthew DeBergeFeinberg Cardiovascular Research Institute, Northwestern University, Chicago, IL, USA; Surgery-Organ Transplantation, Northwestern University, Chicago, IL, USA.
Michael TyeFeinberg Cardiovascular Research Institute, Northwestern University, Chicago, IL, USA; Surgery-Organ Transplantation, Northwestern University, Chicago, IL, USA.
Emily RostlundFeinberg Cardiovascular Research Institute, Northwestern University, Chicago, IL, USA; Surgery-Organ Transplantation, Northwestern University, Chicago, IL, USA.
Dorien SchrijversUniversity of Antwerp, Belgium.
Zheng Jenny ZhangUniversity of Antwerp, Belgium.
Ronen SumaginFeinberg Cardiovascular Research Institute, Northwestern University, Chicago, IL, USA.
Warren G TourtellotteFeinberg Cardiovascular Research Institute, Northwestern University, Chicago, IL, USA; Surgery-Organ Transplantation, Northwestern University, Chicago, IL, USA.
Daniel LeeFeinberg Cardiovascular Research Institute, Northwestern University, Chicago, IL, USA.
Jon LomasneyFeinberg Cardiovascular Research Institute, Northwestern University, Chicago, IL, USA; Surgery-Organ Transplantation, Northwestern University, Chicago, IL, USA.
John MorrowDepartment of Cardiology and Division of Molecular Medicine, Columbia University, New York, NY, USA.
Edward B ThorpFeinberg Cardiovascular Research Institute, Northwestern University, Chicago, IL, USA; Surgery-Organ Transplantation, Northwestern University, Chicago, IL, USA. Electronic address: ebthorp@northwestern.edu.
Northwestern University · USUniversity of Antwerp · BEColumbia University · US

Funding

CELLULAR &MOLECULAR BASIS OF DISEASE TRAINING PROGRAMT32GM008061 · NIGMS · NORTHWESTERN UNIVERSITY · PI CARTHEW, RICHARD W. · 1985 to 2022
$17.1M
Mentoring For Success: Developing Fundamental Skills For Biomedical ResearchR25GM079300 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MCGEE, RICHARD · 2007 to 2020
$6.6M
Efferocytosis-Directed Inflammation Resolution and Repair in the Hypoxic HeartR01HL122309 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI THORP, EDWARD BENJAMIN · 2014 to 2024
$5.0M
IMMEDIATE EARLY GENE REGULATED DEVELOPMENT/PLASTICITYK02NS046468 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI TOURTELLOTTE, WARREN G · 2005 to 2009
$785k
Mentoring and Research in Mouse PathobiologyK26OD010945 · OD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI TOURTELLOTTE, WARREN G · 2012 to 2014
$471k
Mentoring and Research in Mouse PathobiologyK26RR026099 · NCRR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI TOURTELLOTTE, WARREN G · 2010 to 2011
$317k
NCRR NIH HHS K26 RR026099NHLBI NIH HHS 1R01HL122309-01NHLBI NIH HHS R01 HL122309NIGMS NIH HHS R25 GM079300NIGMS NIH HHS T32 GM008061NIH HHS K26 OD010945NINDS NIH HHS K02 NS046468
6 · The paper itself

Abstract

backgroundMobilization of the innate immune response to clear and metabolize necrotic and apoptotic cardiomyocytes is a prerequisite to heart repair after cardiac injury. Suboptimal kinetics of dying myocyte clearance leads to secondary necrosis, and in the case of the heart, increased potential for collateral loss of neighboring non-regenerative myocytes. Despite the importance of myocyte phagocytic clearance during heart repair, surprisingly little is known about its underlying cell and molecular biology.

objectiveTo determine if phagocytic receptor MERTK is expressed in human hearts and to elucidate key sequential steps and phagocytosis efficiency of dying adult cardiomyocytes, by macrophages.

resultsIn infarcted human hearts, expression profiles of the phagocytic receptor MER-tyrosine kinase (MERTK) mimicked that found in experimental ischemic mouse hearts. Electron micrographs of myocardium identified MERTK signal along macrophage phagocytic cups and Mertk-/- macrophages contained reduced digested myocyte debris after myocardial infarction. Ex vivo co-culture of primary macrophages and adult cardiomyocyte apoptotic bodies revealed reduced engulfment relative to resident cardiac fibroblasts. Inefficient clearance was not due to the larger size of myocyte apoptotic bodies, nor were other key steps preceding the formation of phagocytic synapses significantly affected; this included macrophage chemotaxis and direct binding of phagocytes to myocytes. Instead, suppressed phagocytosis was directly associated with myocyte-induced inactivation of MERTK, which was partially rescued by genetic deletion of a MERTK proteolytic susceptibility site.

conclusionUtilizing an ex vivo co-cultivation approach to model key cellular and molecular events found in vivo during infarction, cardiomyocyte phagocytosis was found to be inefficient, in part due to myocyte-induced shedding of macrophage MERTK. These findings warrant future studies to identify other cofactors of macrophage-cardiomyocyte cross-talk that contribute to cardiac pathophysiology.

Indexed as

AnimalsApoptosisCell Linec-Mer Tyrosine KinaseCoculture TechniquesHumansImmunity, InnateMacrophagesMiceMyocardial InfarctionMyocytes, CardiacNecrosisPhagocytosisProto-Oncogene ProteinsReceptor Protein-Tyrosine Kinasesc-Mer Tyrosine KinaseMERTK protein, humanProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesAcute myocardial infarctionAnimal models of human diseaseCardiomyocytePhagocytosis

Identifiers

PMID26316303
PMCPMC4637185
OpenAlexW1642486132

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.